Bio-Rad Laboratories, Inc. (BIO)
370.48
-15.52
(-4.02%)
USD |
NYSE |
Nov 12, 16:00
370.31
-0.17
(-0.05%)
Pre-Market: 20:00
Bio-Rad Laboratories Price to Book Value : 1.310 for Nov. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.310 |
| November 11, 2026 | 1.365 |
| November 10, 2026 | 1.367 |
| November 09, 2026 | 1.373 |
| November 06, 2026 | 1.350 |
| November 05, 2026 | 1.305 |
| November 04, 2026 | 1.344 |
| November 03, 2026 | 1.326 |
| November 02, 2026 | 1.295 |
| October 30, 2026 | 1.316 |
| October 29, 2026 | 1.360 |
| October 28, 2026 | 1.362 |
| October 27, 2026 | 1.348 |
| October 26, 2026 | 1.317 |
| October 23, 2026 | 1.308 |
| October 22, 2026 | 1.286 |
| October 21, 2026 | 1.275 |
| October 20, 2026 | 1.254 |
| October 19, 2026 | 1.248 |
| October 16, 2026 | 1.251 |
| October 15, 2026 | 1.290 |
| October 14, 2026 | 1.282 |
| October 13, 2026 | 1.286 |
| October 12, 2026 | 1.289 |
| October 09, 2026 | 1.295 |
| Date | Value |
|---|---|
| October 08, 2026 | 1.275 |
| October 07, 2026 | 1.301 |
| October 06, 2026 | 1.304 |
| October 05, 2026 | 1.343 |
| October 02, 2026 | 1.306 |
| October 01, 2026 | 1.258 |
| September 30, 2026 | 1.336 |
| September 29, 2026 | 1.415 |
| September 28, 2026 | 1.408 |
| September 25, 2026 | 1.42 |
| September 24, 2026 | 1.444 |
| September 23, 2026 | 1.412 |
| September 22, 2026 | 1.415 |
| September 21, 2026 | 1.406 |
| September 18, 2026 | 1.403 |
| September 17, 2026 | 1.425 |
| September 16, 2026 | 1.413 |
| September 15, 2026 | 1.409 |
| September 14, 2026 | 1.374 |
| September 11, 2026 | 1.376 |
| September 10, 2026 | 1.374 |
| September 09, 2026 | 1.405 |
| September 08, 2026 | 1.417 |
| September 04, 2026 | 1.439 |
| September 03, 2026 | 1.446 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Thermo Fisher Scientific, Inc. | 4.732 |
| Danaher Corp. | 3.046 |
| Agilent Technologies, Inc. | 6.625 |
| Illumina, Inc. | 10.13 |
| Bruker Corp. | 4.031 |
Price to Book Value Related Metrics
| PE Ratio | 9.756 |
| PS Ratio | 3.848 |
| Price to Free Cash Flow | 30.32 |
| Price | 370.48 |
| Earnings Yield | 10.25% |
| Market Cap | 9.963B |
| Operating PE Ratio | 40.58 |
| Normalized PE Ratio | 33.05 |